Sacubitril Sodium is an angiotensin receptor-neprilysin inhibitor utilized in combination with valsartan to manage chronic heart failure, where it functions by inhibiting neprilysin and blocking the renin-angiotensin… Read more
Sacubitril Sodium is an angiotensin receptor-neprilysin inhibitor utilized in combination with valsartan to manage chronic heart failure, where it functions by inhibiting neprilysin and blocking the renin-angiotensin system to improve cardiac performance. Laboratories require precise reference standards to ensure the rigorous quality control and safety of this therapeutic agent. This category encompasses a comprehensive selection of compounds critical for pharmaceutical analysis, including synthetic intermediates, potential degradation products, identified impurities, and stable isotope-labelled standards. These materials are essential for accurate impurity profiling, method development, and the validation of analytical procedures in accordance with regulatory requirements. By providing access to high-quality reference compounds, these tools enable the reliable identification and quantification of impurities and metabolites, supporting the structural verification and batch release testing of the active pharmaceutical ingredient throughout the drug development lifecycle.